Agilent Technologies, Inc.(A)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Diagnostics & Research
Agilent Technologies, Inc. logo

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Latest News & Analysis

Agilent Technologies: Financial analysis, growth prospects, and advancements in CAR T-cell therapy and digital pathology solutions.
Mar 24, 2025

Agilent Technologies: Innovations in Cancer Diagnostics and Market Expansion

Analysis of Agilent Technologies' advancements in cancer diagnostics, EU IVDR certification, digital pathology, and strategic market positioning.

Read more →
Agilent Technologies: Digital Pathology, Cancer Diagnostics, and Market Analysis
Mar 21, 2025

Agilent Technologies: Digital Pathology, Cancer Diagnostics, and Market Analysis

Agilent Technologies navigates digital pathology, EU IVDR compliance, and research innovation, influencing investment decisions and market positioning.

Read more →
Agilent Technologies: Navigating Cancer Diagnostics Growth Amidst Revenue Headwinds - EU IVDR certification, strategic pricing, and APAC challenges analyzed.
Mar 18, 2025

Agilent Technologies: EU IVDR Approval, Earnings Analysis

Agilent faces mixed outlook: EU IVDR boosts cancer diagnostics, but revenue challenges in Asia Pacific and lowered forecasts raise concerns. Strategic pricing is key.

Read more →
Agilent Technologies Faces Mixed Signals: EU IVDR Approval vs. Macroeconomic Challenges. Analyst insights and stock analysis.
Mar 12, 2025

Agilent (A): EU IVDR Approval, Revenue Forecasts, and Market Challenges

Agilent (A) navigates market headwinds with EU IVDR approval and strategic cost-cutting. Revenue forecasts adjusted amid biotech funding slowdown and currency impacts.

Read more →
Agilent Technologies: EU IVDR impact on cancer diagnostics, Q1 2025 results, and strategic market positioning. Analysis of stock performance, revenue trends, and competitive landscape.
Mar 10, 2025

Agilent Technologies: EU IVDR Impact and Revenue Analysis

Agilent Technologies faces mixed market signals as it navigates EU IVDR certifications, soft biotech demand, and international revenue fluctuations. This analysis examines recent developments, financial performance, and strategic initiatives, providing insights for investors.

Read more →
Agilent Technologies (A) Market Update: Analysis of Earnings, Strategy, and Financial Performance Overview | Q1 2025
Mar 6, 2025

Agilent Technologies, Inc.: Earnings & International Growth Analysis

In-depth analysis of [A](/dashboard/companies/A)'s latest Q1 earnings, international expansion, and strategic initiatives backed by robust financial data.

Read more →
Agilent Technologies Q1 2025 earnings preview: Analysis of key metrics, market trends, and automation impact on Agilent's stock.
Feb 26, 2025

Agilent (A): Q1 2025 Earnings Preview - Key Metrics & Impact

Agilent Technologies is set to announce its Q1 2025 earnings on February 26. This report analyzes key expectations and market impact.

Read more →
Agilent Technologies Q1 2025 Earnings Preview: Market analysis, revenue expectations, and strategic outlook. Stay informed on $A stock.
Feb 25, 2025

Agilent Technologies (A): Q1 2025 Earnings Preview and Market Analysis

Agilent Technologies (A) Q1 2025 earnings preview: Analyzing market trends, China regulatory challenges, lab automation competition, and options market sentiment.

Read more →
Agilent Technologies Q1 2025 Earnings Preview: Analysis of Market Dynamics, Analyst Projections, and Strategic Outlook for [A].
Feb 21, 2025

Agilent Q1 2025 Earnings Preview: Key Metrics & Trends

A comprehensive preview of [A](/dashboard/companies/A)'s Q1 2025 earnings, examining analyst projections, market dynamics, and strategic initiatives.

Read more →
Agilent Technologies Q1 2025 earnings preview, analysis of financial results, strategic initiatives, and market trends. Stay informed on Agilent's stock performance and future outlook.
Feb 21, 2025

Agilent Technologies: Q1 2025 Earnings Preview and Key Growth Drivers

A comprehensive intraday update on Agilent Technologies (A), covering financial results, strategic initiatives, and market challenges. Data-driven insights for investors.

Read more →
Agilent Technologies Q1 2025 Earnings Preview: Automation, Market Challenges, and Analyst Expectations.
Feb 20, 2025

Agilent Technologies Q1 2025 Earnings Preview: Automation and Market Challenges

Agilent Technologies gears up for Q1 2025 results amid automation push and market headwinds. Analysts eye margin expansion and China impact.

Read more →